Fairmount Funds Management LLC

Director

Director at Spyre Therapeutics, Inc., filing insider transactions between 2025-10-07 and 2026-06-23. Also reports transactions at 3 other companies.

Total Purchases

$39.0M

4 transactions

Total Sales

$642.3M

2 transactions

Companies Traded

6 total filings

Active Since

2025-10-07

Last: 2026-06-23

Companies

Spyre Therapeutics, Inc.

Viridian Therapeutics, Inc.\DE

Zenas BioPharma, Inc.

Cogent Biosciences, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-23	SYRE	Sale	4.68M	$85.31	$399.7M	0	SEC ↗
2026-05-11	VRDN	Purchase	1.18M	$17.00	$20.0M	5.09M	SEC ↗
2026-03-31	ZBIO	Purchase	150.0K	$20.00	$3.0M